Tremfya Side Effects
Generic name: guselkumab
Note: This document provides detailed information about Tremfya Side Effects associated with guselkumab. Some dosage forms listed on this page may not apply specifically to the brand name Tremfya.
Applies to guselkumab: subcutaneous solution.
Serious side effects of Tremfya
Along with its needed effects, guselkumab (the active ingredient contained in Tremfya) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking guselkumab:
More common side effects
Less common side effects
Rare side effects
Other side effects of Tremfya
Some side effects of guselkumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
- difficulty in moving
- muscle pain or stiffness
- pain in the joints
Rare side effects
- redness of the skin
For healthcare professionals
Applies to guselkumab: intravenous solution, subcutaneous solution.
Immunologic adverse events
- Very common (10% or more): Infections (23%)
- Common (1% to 10%): Tinea infections, herpes simplex infections, immunogenicity[Ref]
Local
- Common (1% to 10%): Injection site reactions (e.g., injection site erythema, bruising, hematoma, hemorrhage, swelling, edema, pruritus, pain, discoloration, induration, inflammation, urticaria)[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia[Ref]
Hepatic
- Common (1% to 10%): Elevated liver enzymes[Ref]
Respiratory
- Very common (10% or more): Respiratory tract infection (e.g., nasopharyngitis, upper respiratory tract infection, pharyngitis, viral upper respiratory tract infection) (14%)[Ref]
Nervous system
- Common (1% to 10%): Headache[Ref]
Gastrointestinal
- Common (1% to 10%): Diarrhea, gastroenteritis (including viral gastroenteritis)[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Hypersensitivity
- Frequency not reported: Anaphylaxis[Ref]
Dermatologic
- Common (1% to 10%): Urticaria, rash[Ref]
References
1. (2017) "Product Information. Tremfya (guselkumab)." Janssen Biotech, Inc.
Frequently asked questions
- What are monoclonal antibodies?
- How long does it take for Tremfya to work?
- How and where do you inject Tremfya?
- How long can Tremfya be out of the fridge?
- Can Tremfya cause cancer?
- Is Tremfya a biological?
- What are the new drugs for plaque psoriasis?
- What causes Plaque Psoriasis?
- How does Tremfya work?
More about Tremfya (guselkumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (100)
- Drug images
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Tremfya side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.